Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Cardiovascular risk of selective cyclooxygenase-2 inhibitors.

Schrör K, Mehta P, Mehta JL. Cardiovascular risk of selective cyclooxygenase-2 inhibitors. J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):95-101.

View in: PubMed

collapse authors with profiles